NDRG1 Signaling Is Essential for Endothelial Inflammation and Vascular Remodeling

被引:28
|
作者
Zhang, Guanxin [1 ,2 ]
Qin, Qing [1 ]
Zhang, Chen [1 ]
Sun, Xiaobo [1 ]
Kazama, Kyosuke [1 ]
Yi, Bing [1 ]
Cheng, Fang [1 ]
Guo, Zhi-Fu [1 ,3 ]
Sun, Jianxin [1 ]
机构
[1] Thomas Jefferson Univ, Ctr Translat Med, 1020 Locust St,Room 368G, Philadelphia, PA 19107 USA
[2] Naval Med Univ, Changhai Hosp, Inst Cardiothorac Surg, Shanghai, Peoples R China
[3] Thomas Jefferson Univ, Ctr Translat Med, 1020 Locust St,Room 381, Philadelphia, PA 19107 USA
关键词
AP-1; Nur77; endothelial cells; inflammation; NDRG1; NF-kappa B; NF-KAPPA-B; VON-WILLEBRAND-FACTOR; NUCLEAR RECEPTOR NUR77; MOUSE CAROTID-ARTERY; THROMBOMODULIN EXPRESSION; METASTASIS SUPPRESSOR; GENE; ACTIVATION; CELLS; ATHEROSCLEROSIS;
D O I
10.1161/CIRCRESAHA.122.321837
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND: NDRG-1 (N-myc downstream-regulated gene 1) is a member of NDRG family that plays essential roles in cell differentiation, proliferation, and stress responses. Although the expression of NDRG1 is regulated by fluid shear stress, its roles in vascular biology remain poorly understood. The purpose of the study is to determine the functional significance of NDRG1 in vascular inflammation and remodeling. METHODS AND RESULTS: By using quantitative polymerase chain reaction, western blot, and immunohistochemistry,we demonstrate that the expression of NDRG1 is markedly increased in cytokine-stimulated endothelial cells and in human and mouse atherosclerotic lesions. To determine the role of NDRG1 in endothelial activation, we performed loss-of-function studies using NDRG1 short hairpin RNA. Our results demonstrate that NDRG1 knockdown by lentivirus bearing NDRG1 short hairpin RNA substantially attenuates both IL-1 beta (interleukin-1 beta) and TNF-alpha (tumor necrosis factor-alpha)-induced expression of cytokines/chemokines and adhesion molecules. Intriguingly, inhibition of NDRG1 also significantly attenuates the expression of procoagulant molecules, such as PAI-1 (plasminogen activator inhibitor type 1) and TF (tissue factor), and increases the expression of TM (thrombomodulin) and t-PA (tissue-type plasminogen activator), thus exerting potent antithrombotic effects in endothelial cells. Mechanistically, we showed that NDRG1 interacts with orphan Nur77 (nuclear receptor) and functionally inhibits the transcriptional activity of Nur77 and NF-kappa B (nuclear factor Kappa B) in endothelial cells. Moreover, in NDRG1 knockdown cells, both cytokine-induced mitogen-activated protein kinase activation, c-Jun phosphorylation, and AP-1 (activator protein 1) transcriptional activity are substantially inhibited. Neointima and atherosclerosis formation induced by carotid artery ligation and arterial thrombosis were markedly attenuated in endothelial cell-specific NDRG1 knockout mice compared with their wild-type littermates.CONCLUSIONS: Our results for the first time identify NDRG1 as a critical mediator implicated in regulating endothelial inflammation, thrombotic responses, and vascular remodeling, and suggest that inhibition of NDRG1 may represent a novel therapeutic strategy for inflammatory vascular diseases, such as atherothrombosis and restenosis.
引用
收藏
页码:306 / 319
页数:14
相关论文
共 50 条
  • [31] Ndrg1 promotes adipocyte differentiation and sustains their function
    Cai, Kai
    El-Merahbi, Rabih
    Loeffler, Mona
    Mayer, Alexander E.
    Sumara, Grzegorz
    SCIENTIFIC REPORTS, 2017, 7
  • [32] 分化相关基因NDRG1与肿瘤
    王震
    王国英
    王芳
    中华病理学杂志, 2003, (02) : 65 - 67
  • [33] Ndrg1 promotes adipocyte differentiation and sustains their function
    Kai Cai
    Rabih El-Merahbi
    Mona Loeffler
    Alexander E. Mayer
    Grzegorz Sumara
    Scientific Reports, 7
  • [34] NDRG1 and lymph nodes status in breast cancer
    Kometova, V.
    Mikhaleva, L.
    Rodionova, M.
    Rodionov, V.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S69 - S69
  • [35] NDRG1 protein overexpression in malignant thyroid neoplasms
    Gerhard, Rene
    Nonogaki, Suely
    Tavares Guerreiro Fregnani, Jose Humberto
    Soares, Fernando Augusto
    Nagai, Maria Aparecida
    CLINICS, 2010, 65 (08) : 757 - 762
  • [36] NDRG1: EVIDENCE FOR A SECOND FOUNDER MUTATION IN BULGARIA
    Atkinson, D.
    De Vriendt, E.
    Bozhinova, V
    Guergueltcheva, V
    Estrada-Cuzcano, E.
    Kalaydjieva, L.
    Tournev, I
    Jordanova, A.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2016, 21 (03) : 234 - 234
  • [37] Pathological and electrophysiological studies of NDRG1 mutant mice
    King, R. H. M.
    Blake, J.
    Muddle, J. R.
    Orrell, R. W.
    Morahan, G.
    Kalaydjieva, L.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2007, 12 : 44 - 44
  • [38] The role of the NDRG1 in the pathogenesis and treatment of breast cancer
    Zhao, Xiao
    Richardson, Des R.
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2023, 1878 (03):
  • [39] SUMO modification regulates the protein stability of NDRG1
    Lee, Jae Eun
    Kim, Jung Hwa
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2015, 459 (01) : 161 - 165
  • [40] NDRG1 and CRK-I/II are regulators of endothelial cell migration under intermittent hypoxia
    Sébastien Toffoli
    Edouard Delaive
    Marc Dieu
    Olivier Feron
    Martine Raes
    Carine Michiels
    Angiogenesis, 2009, 12 : 339 - 354